
|Videos|October 5, 2017
Addressing Issues Surrounding Current Antibiotic Development
Author(s)Contagion® Editorial Staff
James S. Lewis, PharmD, FIDSA, addresses the issues that surround current antibiotic development.
Advertisement
James S. Lewis, PharmD, FIDSA, Co-Director of Antibiotic Stewardship, Oregon Health and Science University, addresses the issues that surround current antibiotic development. The primary issue involves a common perception shared by some pharmaceutical companies regarding return on investment.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Measles Update: January 30, 2026
2
Vaccines and Febrile Seizures: What Everyone Should Know
3
Top Infectious Disease News Stories Week of January 24 - January 30
4
AAP Releases its Recommended 2026 Childhood and Adolescent Immunization Schedule
5

































































































































